カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の咳喘息（CVA）治療薬市場予測2023-2029：気管支拡張剤、ロイコトリエン拮抗剤、肥満細胞安定剤、コルチコステロイド、モノクローナル抗体

【英語タイトル】Cough Variant Asthma (CVA) Treatment Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23FB2176）・商品コード：MMG23FB2176
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年2月
・ページ数：66
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の咳喘息（CVA）治療薬市場規模と予測を収録しています。・世界の咳喘息（CVA）治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の咳喘息（CVA）治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の咳喘息（CVA）治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「気管支拡張剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

咳喘息（CVA）治療薬のグローバル主要企業は、GlaxoSmithKline、Merck & Co、AstraZeneca、F. Hoffmann-La Roche、Teva Pharmaceutical、Novartis International、Boehringer Ingelheim、Sunovion Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、咳喘息（CVA）治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の咳喘息（CVA）治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の咳喘息（CVA）治療薬市場：タイプ別市場シェア、2022年
・気管支拡張剤、ロイコトリエン拮抗剤、肥満細胞安定剤、コルチコステロイド、モノクローナル抗体

世界の咳喘息（CVA）治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の咳喘息（CVA）治療薬市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の咳喘息（CVA）治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の咳喘息（CVA）治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における咳喘息（CVA）治療薬のグローバル売上、2018年-2023年
・主要企業における咳喘息（CVA）治療薬のグローバル売上シェア、2022年
・主要企業における咳喘息（CVA）治療薬のグローバル販売量、2018年-2023年
・主要企業における咳喘息（CVA）治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GlaxoSmithKline、Merck & Co、AstraZeneca、F. Hoffmann-La Roche、Teva Pharmaceutical、Novartis International、Boehringer Ingelheim、Sunovion Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
咳喘息（CVA）治療薬市場の定義
市場セグメント
世界の咳喘息（CVA）治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の咳喘息（CVA）治療薬市場規模
世界の咳喘息（CVA）治療薬市場規模：2022年 VS 2029年
世界の咳喘息（CVA）治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの咳喘息（CVA）治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の咳喘息（CVA）治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：気管支拡張剤、ロイコトリエン拮抗剤、肥満細胞安定剤、コルチコステロイド、モノクローナル抗体
咳喘息（CVA）治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
咳喘息（CVA）治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別咳喘息（CVA）治療薬市場規模 2022年と2029年
地域別咳喘息（CVA）治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GlaxoSmithKline、Merck & Co、AstraZeneca、F. Hoffmann-La Roche、Teva Pharmaceutical、Novartis International、Boehringer Ingelheim、Sunovion Pharmaceuticals
…

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Cough Variant Asthma (CVA) Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cough Variant Asthma (CVA) Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cough Variant Asthma (CVA) Treatment Drug Overall Market Size
2.1 Global Cough Variant Asthma (CVA) Treatment Drug Market Size: 2022 VS 2029
2.2 Global Cough Variant Asthma (CVA) Treatment Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cough Variant Asthma (CVA) Treatment Drug Players in Global Market
3.2 Top Global Cough Variant Asthma (CVA) Treatment Drug Companies Ranked by Revenue
3.3 Global Cough Variant Asthma (CVA) Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Cough Variant Asthma (CVA) Treatment Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cough Variant Asthma (CVA) Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cough Variant Asthma (CVA) Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Cough Variant Asthma (CVA) Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Cough Variant Asthma (CVA) Treatment Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Cough Variant Asthma (CVA) Treatment Drug Market Size Markets, 2022 & 2029
4.1.2 Bronchodilators
4.1.3 Leukotriene Antagonists
4.1.4 Mast Cell Stabilizers
4.1.5 Corticosteroids
4.1.6 Monoclonal Antibody
4.2 By Type – Global Cough Variant Asthma (CVA) Treatment Drug Revenue & Forecasts
4.2.1 By Type – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2023
4.2.2 By Type – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2024-2029
4.2.3 By Type – Global Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cough Variant Asthma (CVA) Treatment Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Cough Variant Asthma (CVA) Treatment Drug Revenue & Forecasts
5.2.1 By Application – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2023
5.2.2 By Application – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2024-2029
5.2.3 By Application – Global Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Cough Variant Asthma (CVA) Treatment Drug Market Size, 2022 & 2029
6.2 By Region – Global Cough Variant Asthma (CVA) Treatment Drug Revenue & Forecasts
6.2.1 By Region – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2023
6.2.2 By Region – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2024-2029
6.2.3 By Region – Global Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2029
6.3.2 US Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.3.3 Canada Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.3.4 Mexico Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2029
6.4.2 Germany Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.3 France Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.4 U.K. Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.5 Italy Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.6 Russia Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.7 Nordic Countries Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.8 Benelux Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2029
6.5.2 China Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.5.3 Japan Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.5.4 South Korea Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.5.5 Southeast Asia Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.5.6 India Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2029
6.6.2 Brazil Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.6.3 Argentina Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2029
6.7.2 Turkey Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.7.3 Israel Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.7.5 UAE Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
7 Cough Variant Asthma (CVA) Treatment Drug Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.1.4 GlaxoSmithKline Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Merck & Co
7.2.1 Merck & Co Company Summary
7.2.2 Merck & Co Business Overview
7.2.3 Merck & Co Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.2.4 Merck & Co Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.2.5 Merck & Co Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.3.4 AstraZeneca Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Company Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.4.4 F. Hoffmann-La Roche Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.4.5 F. Hoffmann-La Roche Key News & Latest Developments
7.5 Teva Pharmaceutical
7.5.1 Teva Pharmaceutical Company Summary
7.5.2 Teva Pharmaceutical Business Overview
7.5.3 Teva Pharmaceutical Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.5.4 Teva Pharmaceutical Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.5.5 Teva Pharmaceutical Key News & Latest Developments
7.6 Novartis International
7.6.1 Novartis International Company Summary
7.6.2 Novartis International Business Overview
7.6.3 Novartis International Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.6.4 Novartis International Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.6.5 Novartis International Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.7.4 Boehringer Ingelheim Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Sunovion Pharmaceuticals
7.8.1 Sunovion Pharmaceuticals Company Summary
7.8.2 Sunovion Pharmaceuticals Business Overview
7.8.3 Sunovion Pharmaceuticals Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.8.4 Sunovion Pharmaceuticals Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.8.5 Sunovion Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Cough Variant Asthma (CVA) Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Cough Variant Asthma (CVA) Treatment Drug Market Drivers in Global Market
Table 3. Cough Variant Asthma (CVA) Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Cough Variant Asthma (CVA) Treatment Drug in Global Market
Table 5. Top Cough Variant Asthma (CVA) Treatment Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cough Variant Asthma (CVA) Treatment Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cough Variant Asthma (CVA) Treatment Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cough Variant Asthma (CVA) Treatment Drug Product Type
Table 9. List of Global Tier 1 Cough Variant Asthma (CVA) Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cough Variant Asthma (CVA) Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cough Variant Asthma (CVA) Treatment Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cough Variant Asthma (CVA) Treatment Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cough Variant Asthma (CVA) Treatment Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cough Variant Asthma (CVA) Treatment Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cough Variant Asthma (CVA) Treatment Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cough Variant Asthma (CVA) Treatment Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2024-2029
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Cough Variant Asthma (CVA) Treatment Drug Product Offerings
Table 32. GlaxoSmithKline Cough Variant Asthma (CVA) Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Merck & Co Company Summary
Table 35. Merck & Co Cough Variant Asthma (CVA) Treatment Drug Product Offerings
Table 36. Merck & Co Cough Variant Asthma (CVA) Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Merck & Co Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Cough Variant Asthma (CVA) Treatment Drug Product Offerings
Table 40. AstraZeneca Cough Variant Asthma (CVA) Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. F. Hoffmann-La Roche Company Summary
Table 43. F. Hoffmann-La Roche Cough Variant Asthma (CVA) Treatment Drug Product Offerings
Table 44. F. Hoffmann-La Roche Cough Variant Asthma (CVA) Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 45. F. Hoffmann-La Roche Key News & Latest Developments
Table 46. Teva Pharmaceutical Company Summary
Table 47. Teva Pharmaceutical Cough Variant Asthma (CVA) Treatment Drug Product Offerings
Table 48. Teva Pharmaceutical Cough Variant Asthma (CVA) Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Teva Pharmaceutical Key News & Latest Developments
Table 50. Novartis International Company Summary
Table 51. Novartis International Cough Variant Asthma (CVA) Treatment Drug Product Offerings
Table 52. Novartis International Cough Variant Asthma (CVA) Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis International Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Cough Variant Asthma (CVA) Treatment Drug Product Offerings
Table 56. Boehringer Ingelheim Cough Variant Asthma (CVA) Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Sunovion Pharmaceuticals Company Summary
Table 59. Sunovion Pharmaceuticals Cough Variant Asthma (CVA) Treatment Drug Product Offerings
Table 60. Sunovion Pharmaceuticals Cough Variant Asthma (CVA) Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Sunovion Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Cough Variant Asthma (CVA) Treatment Drug Segment by Type in 2022
Figure 2. Cough Variant Asthma (CVA) Treatment Drug Segment by Application in 2022
Figure 3. Global Cough Variant Asthma (CVA) Treatment Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cough Variant Asthma (CVA) Treatment Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cough Variant Asthma (CVA) Treatment Drug Revenue in 2022
Figure 8. By Type - Global Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
Figure 16. US Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
Figure 20. Germany Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
Figure 28. China Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cough Variant Asthma (CVA) Treatment Drug Revenue, (US$, Mn), 2018-2029
Figure 41. GlaxoSmithKline Cough Variant Asthma (CVA) Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck & Co Cough Variant Asthma (CVA) Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AstraZeneca Cough Variant Asthma (CVA) Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. F. Hoffmann-La Roche Cough Variant Asthma (CVA) Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Teva Pharmaceutical Cough Variant Asthma (CVA) Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis International Cough Variant Asthma (CVA) Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Boehringer Ingelheim Cough Variant Asthma (CVA) Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sunovion Pharmaceuticals Cough Variant Asthma (CVA) Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の咳喘息（CVA）治療薬市場予測2023-2029：気管支拡張剤、ロイコトリエン拮抗剤、肥満細胞安定剤、コルチコステロイド、モノクローナル抗体] (コード：MMG23FB2176)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の咳喘息（CVA）治療薬市場予測2023-2029：気管支拡張剤、ロイコトリエン拮抗剤、肥満細胞安定剤、コルチコステロイド、モノクローナル抗体]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 喘息・COPD薬のグローバル市場（2023～2028）：気管支拡張剤、抗炎症薬、モノクローナル抗体、配合剤
  • 世界の新型コロナウイルス感染症治療薬市場（2022-2031）：薬剤クラス別（コルチコステロイド、抗ウイルス剤、モノクローナル抗体、キナーゼ阻害剤、その他（抗炎症剤、回復期血漿、その他））
  • 世界の尿路感染症（UTI）治療薬市場予測2023-2029：ジェネリック医薬品、先発医薬品
  • 世界の先天性高インスリン症（HI）治療薬市場予測2023-2029：ジアゾキシド、オクトレオチド、グルカゴン、その他
  • 世界の生物学的治療薬市場予測2023-2029：モノクローナル抗体、治療用タンパク質、ワクチン
  • 世界の多発性硬化症（MS）治療薬市場予測2023-2029：コパキソン（グラチラマー酢酸塩）、ノバントロン（ミトキサントロン）、ジレニア（フィンゴリモド、Fty720）、オーバジオ（テリフルノミド）、テクフィデラ（フマル酸ジメチル）、フィラテグラスト（Sb683699、T-0047）、シポニモド（Baf312）、その他
  • 世界のベーチェット病市場2022-2029：治療種類別（コルチコステロイド、免疫抑制剤＆免疫調節剤）、症状別、地域別
  • 世界のVDAC1抗体市場予測2023-2029：モノクローナル抗体、ポリクローナル抗体

    • ◆H&Iグローバルリサーチのお客様（例）◆